Tuesday, June 30, 2020

US charges generic drug firm Glenmark with price-fixing

US charges generic drug firm Glenmark with price-fixing Glenmark allegedly conspired with pharmaceutical maker Apotex Corp and other generic drug companies to increase the prices of cholesterol medication pravastatin and other generic drugs, the department said.

from Moneycontrol Business News https://ift.tt/2NLNhjW
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

IREDA shares rise 1.1% as board announces meeting date for fund raise via QIP

IREDA shares rose by 1.1% to Rs 209.50 on news of a board meeting set for January 23, 2025, to approve fund-raising via Qualified Institutio...